VolitionRx filed a registration statement with the Securities and Exchange Commission on August 5, 2025.
2 reports, 1 independent
Updated Aug 5
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
VolitionRx filed a registration statement with the Securities and Exchange Commission on August 5, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.UK company VolitionRx filed a registration statement with the SEC.1 source
VolitionRx utilizes the Nu.Q® Discover platform for profiling services.1 source
Keep exploring
The entities involved
-
VolitionRx (United Kingdom)
organization
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- The Securities and Exchange Commission approved registration statements for Lycia Therapeutics, Inc. on October 1, 2026.
- A company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.
- Crawford & Company filed its 10-Q report with the Securities and Exchange Commission on November 3, 2026.
- Kroger filed required documents with the Securities and Exchange Commission regarding stock transactions.
- EVgo filed required documents with the SEC and its board reviewed an unsolicited acquisition proposal.
Coverage
Newest first; wire copies grouped- PR NewswireVolitionRx Announces Pricing of $1.2 Million Registered Direct Offering HENDERSON, Nev., Aug. 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition" or the "Company"), a multi-n
- PR NewswireNu.Q® Discover Expands Global Adoption and Epigenetic Innovation HENDERSON, Nev., July 16, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics com